Dr. Charles D Bissell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 Lamb Cir, Suite 300, Christiansburg, VA 24073 Phone: 540-639-5900 Fax: 540-639-0976 |
Dr. Alex A Tan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2900 Lamb Cir, Suite 300, Christiansburg, VA 24073 Phone: 540-639-5900 Fax: 540-639-0976 |
Charles A Harris, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2900 Lamb Cir, Suite 302, Christiansburg, VA 24073 Phone: 540-731-7600 Fax: 540-639-5400 |
Keith R Stephenson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 Lamb Cir, Suite 300, Christiansburg, VA 24073 Phone: 540-639-5900 Fax: 540-639-0976 |
Dr. Ashish Raju, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 Lamb Cir, Suite 301, Christiansburg, VA 24073 Phone: 540-731-7600 |
Lamiere Joseph Downing, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 Lamb Cir, Suite 300, Christiansburg, VA 24073 Phone: 540-639-5900 |
Dr. Caleb Pagliasotti, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2900 Tyler Rd, Christiansburg, VA 24073 Phone: 540-731-7314 |
Robin D Minks, DO Surgery Medicare: Not Enrolled in Medicare Practice Location: 80 College St, Suite R, Christiansburg, VA 24073 Phone: 540-260-9080 Fax: 540-260-9077 |
Ms. Jann L Holwick, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1095 N. Franklin St., Christiansburg, VA 24073 Phone: 304-647-0677 Fax: 309-758-5035 |
News Archive
The increases are largely set to hit small businesses, individual plans and long-term care coverage.
In Medicare news, the drug maker Dendreon says federal officials have said they will pay doctors to administer the drug. Also, policymakers are studying Medigap to see if curbs on those policies could help cut Medicare costs.
The current study reports the effective reproduction number of B.1.1.519 and presents its geographical origin based on phylogenetic analysis.
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
The Supreme Court justice's ruling affects a number of faith-based groups. She asked for an administration response by tomorrow.
› Verified 8 days ago